48.62

3.99% -2.02

Vera Therapeutics Inc (VERA)

Overview News Price History Option Chain Financials Discussions Forecast

Vera Therapeutics Inc stock is traded at $48.62, with a volume of 1.03M. It is down -3.99% in the last 24 hours and up +30.52% over the past month. Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Previous Close:

$50.64

Open:

$50.745

24h Volume:

1.03M

Relative Volume:

0.69

Market Cap:

$3.45B

Revenue:

Net Income/Loss:

$-218.28M

P/E Ratio:

-13.58

EPS:

-3.5803

Net Cash Flow:

$-186.55M

1W Performance:

-9.26%

1M Performance:

+30.52%

6M Performance:

+105.58%

1Y Performance:

+15.21%

1-Day Range:

$47.94

$50.84

1-Week Range:

$47.94

$53.76

52-Week Range:

$18.53

$56.05

Vera Therapeutics Inc Stock (VERA) Company Profile

Name

Vera Therapeutics Inc

Sector

Healthcare (1131)

Industry

Biotechnology (631)

Phone

650-770-0077

Address

2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE

Employee

224

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

VERA's Discussions on Twitter

Compare VERA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VERA Vera Therapeutics Inc	48.62	3.59B	0	-218.28M	-186.55M	-3.5803
VRTX Vertex Pharmaceuticals Inc	452.13	115.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.31	81.12B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.17	52.54B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	839.99	51.78B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.12	37.12B	447.02M	-1.18B	-906.14M	-6.1812

Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-16-25	Initiated	BofA Securities	Buy
Aug-04-25	Downgrade	Wolfe Research	Outperform → Peer Perform
May-05-25	Resumed	H.C. Wainwright	Buy
Feb-04-25	Initiated	Wolfe Research	Outperform
Jan-28-25	Initiated	Goldman	Buy
Nov-21-24	Initiated	Wells Fargo	Overweight
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Jan-25-24	Initiated	Oppenheimer	Outperform
Jan-08-24	Initiated	Cantor Fitzgerald	Overweight
Dec-18-23	Initiated	Raymond James	Outperform
Nov-10-23	Upgrade	Jefferies	Hold → Buy
Aug-16-23	Initiated	Guggenheim	Buy
Jan-04-23	Downgrade	Jefferies	Buy → Hold
Jan-04-23	Downgrade	Wedbush	Outperform → Neutral
Jul-12-22	Initiated	JP Morgan	Overweight
May-02-22	Initiated	H.C. Wainwright	Buy
Apr-19-22	Initiated	Wedbush	Outperform

View All

Vera Therapeutics Inc Stock (VERA) Latest News

Dec 31, 2025

Quarterly Earnings: Will Vera Therapeutics Inc stock attract ESG investors2025 Market Trends & Accurate Technical Buy Alerts - moha.gov.vn

Dec 31, 2025

Stock Traders Purchase Large Volume of Vera Therapeutics Call Options (NASDAQ:VERA) - MarketBeat

Dec 31, 2025

Dec 30, 2025

Vera Therapeutics stock drops 3% today as biotech slips into year-end trading - ts2.tech

Dec 30, 2025

Dec 29, 2025

Vera Therapeutics announces $200M public offering - MSN

Dec 29, 2025

Dec 28, 2025

Entry Recap: What risks investors should watch in Vera Therapeutics Inc stockJuly 2025 Momentum & Consistent Return Investment Signals - moha.gov.vn

Dec 28, 2025

Vera Therapeutics price target raised to $33 from $23 at Wedbush - MSN

Dec 28, 2025

50,000 Shares in Vera Therapeutics, Inc. $VERA Purchased by Swedbank AB - MarketBeat

Dec 28, 2025

450,700 Shares in Vera Therapeutics, Inc. $VERA Acquired by Capricorn Fund Managers Ltd - MarketBeat

Dec 28, 2025

Dec 26, 2025

Vera Therapeutics (VERA) Stock Dips in Thin Post‑Christmas Trading as Wall Street Weighs FDA Filing, $300M Raise, and IgA Nephropathy Competition - ts2.tech

Dec 26, 2025

Dec 25, 2025

Vera Therapeutics (NASDAQ:VERA) Sets New 1-Year HighShould You Buy? - MarketBeat

Dec 25, 2025

Dec 24, 2025

Vera Therapeutics Earnings Notes - Trefis

Dec 24, 2025

Dec 23, 2025

Trading Systems Reacting to (VERA) Volatility - Stock Traders Daily

Dec 23, 2025

Vera Therapeutics (VERA): Reassessing Valuation After Analyst Upgrades and Cash Boost for Atacicept Launch Prospects - Sahm

Dec 23, 2025

Dec 21, 2025

Vera Therapeutics Appoints James R. Meyers to Board - MSN

Dec 21, 2025

Vera’s New Capital Raise and Legal Transition Might Change The Case For Investing In Vera Therapeutics (VERA) - Sahm

Dec 21, 2025

Dec 20, 2025

How risky is Vera Therapeutics Inc. stock now2025 Market Overview & Smart Swing Trading Alerts - Улправда

Dec 20, 2025

Weekly Earnings: How Vera Therapeutics Inc. stock valuations compare to rivalsJuly 2025 EndofMonth & Momentum Based Trading Ideas - ulpravda.ru

Dec 20, 2025

Recap Report: Will Vera Therapeutics Inc. stock attract ESG investorsLong Setup & Long-Term Safe Investment Plans - moha.gov.vn

Dec 20, 2025